RESUMEN
Transforming growth factor ß (TGF-ß) is a pleiotropic cytokine expressed by a wide range of cell types and is known for hampering the effectiveness of cancer immune cell therapeutic approaches. We have designed a novel construct containing the extracellular domain of the TGF-ß receptor II linked to a glycosylphosphatidylinositol (GPI) anchor (GPI-ecto-TßRII) lacking the transmembrane and cytoplasmic signaling domain of TGF-ß receptor II (TßRII). T cells transduced with lentivirus expressing the GPI-ecto-TßRII construct show 5 to 15 times higher membrane expression compared with a previously established dominant-negative receptor carrying a truncated signaling domain. GPI-ecto-TßRII expression renders T cells unresponsive to TGF-ß-induced signaling seen by a lack of SMAD phosphorylation upon exogeneous TGF-ß treatment. Transduced T cells continue to express high levels of IFNγ and granulocyte-macrophage colony-stimulating factor (GM-CSF), among other cytokines, in the presence of TGF-ß while cytokine expression in untransduced T cells is being markedly suppressed. Furthermore, T cells expressing GPI-ecto-TßRII constructs have been shown to efficiently capture and inactivate TGF-ß from their environment. These results indicate the potential benefits of GPI-ecto-TßRII expressing cytotoxic T cells (CTLs) in future cell therapies.
RESUMEN
We report the case of a patient with an unruptured internal carotid artery (ICA) aneurysm treated with bare platinum coils. The patient had seizures 1 month after treatment. Postoperative imaging showed perianeurysmal edema and enhancement of the aneurismal wall. After aneurysm coiling, perianeurysmal edema is an unusual complication that can be asymptomatic or cause symptoms depending on its location. Epilepsy as a clinical presentation of perianeurysmal edema has not previously been reported. Literature about post-embolization perianeurysmal edema is reviewed.